Global Pharmaceutical Contract Sales Organizations Market to 2030: Adoption of Digital Technologies Bolsters Growth - ResearchAndMarkets.com

High adoption of new technologies for contract sales by pharmaceutical contract sales organizations (CSO), an increase in the interest among end-users to increase the sales of biopharmaceutical and small molecule drugs, and the surge in demand for reducing the cost associated with in-house sales are some of the key factors supporting the growth of the industry.